02637 HAIXI PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 6.31X | Oper Margin | 35.0% |
|---|---|---|---|
| LT Debt/Equity | 1.5% | Net Margin | 30.4% |
| Total Debt/Equity | 6.9% | Return on Equity | 11.1% |
| Price/Book | 7.84X | Return on Assets | 9.6% |
| (HKD 176.700) | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 197.05 | 144.72 | 129.46 | 77.34 |
|---|---|---|---|---|
| Net Profit Growth (%) | +36.2 | +11.8 | +67.4 | N/A |
| Earnings Per Share (HKD) | 2.835 | 2.153 | 1.926 | 1.203 |
| Earnings Per Share Growth (%) | +31.7 | +11.8 | +60.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 62.33 | 82.06 | 91.73 | 146.83 |
| Yield (%) | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 22.539 | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 582.358 | 466.683 | +24.8 | 316.633 |
| Operating Result | 198.076 | 148.994 | +32.9 | 132.846 |
| Profit Before Taxation | 198.076 | 148.994 | +32.9 | 132.813 |
| Taxation | 21.047 | 12.915 | +63.0 | 15.359 |
| Profit /( Loss) After Taxation | 177.029 | 136.079 | +30.1 | 117.454 |
| Net Profit | 177.029 | 136.079 | +30.1 | 117.454 |
| Earnings Per Share () | 2.8350 | 2.1533 | +31.7 | 1.9263 |
| Announcement Date | 2026-03-30 | 2025-10-09 | NA | 2025-10-09 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
